Value Added Medicines: Time to adjust the HTA Decision Frameworks for more patient-centric innovation

5 September 2017

A new study “Value Added Medicines: Time to Adjust the […]

Europäer zahlen zu viel für Pillen

18 July 2017

“É possível fazer os médicos portugueses prescreverem mais genéricos”

18 July 2017

Jacek Glinka: “Biossimilares podem poupar ao SNS 120 milhões de euros”

18 July 2017

Pharma expert: EU drug agency should be ‘easily’ accessible to all

18 July 2017

Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health

16 June 2017

Biosimilar medicines are transforming treatment by enabling better access to […]

Over 100 Participants Explore Opportunities to Ensure Universal Access to Health

27 April 2017

Over 100 participants explored different ways and opportunities to ensure […]

22^nd EAHP Conference in Cannes

25 March 2017

A special satellite  symposium was organized on “Value added medicines […]

Access to Medicines at Sustainable Price: Pharma Industry and Governments Transforming Challenges into Opportunities

23 March 2017

Stimulating Investment in European Generic, Biosimilar and Value Added Medicines through a Transparent Legal Environment

22 March 2017

Key authorities, eminent lawyers and industry leaders discussed today in […]